Find Clinical Trials
Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with bevacizumab in patients with recurrent glioblastoma multiforme
Servier Protocol Code:
CL1-49076-002
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2013-003079-37
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Solid tumors
- S049076
Other study id numbers
Other identification numbers the study may be known by.
- CL1-49076-002